chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hurt for a day or two; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Hurt for a day or two) in a 73-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (Patient had a mild case of COVID-19. She was given Molnupiravir.) on 15-Sep-2022. Previously administered products included for Product used for unknown indication: Pfizer (1st dose Pfizer lot number EL3249) on 15-Jan-2021, Pfizer (2nd dose Pfizer lot number EL9264) on 15-Feb-2021, Pfizer (3rd dose Pfizer booster lot number FE3590) on 13-Oct-2021, Pfizer (4th dose Pfizer lot number FK9994) on 05-May-2022 and PFIZER BIONTECH COVID-19 VACCINE (5th dose Pfizer unknown.) in December 2022; for Osteoporosis: Flu shot and Prolia for osteoporosis and Flu shot and Prolia for osteoporosis; for COVID-19: Molnupiravir. Past adverse reactions to the above products included No adverse event with Flu shot and Prolia for osteoporosis, Flu shot and Prolia for osteoporosis, Molnupiravir, PFIZER BIONTECH COVID-19 VACCINE, Pfizer, Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Osteoporosis (Caller had osteoporosis.), DVT and Pulmonary embolism. Concomitant products included RIVAROXABAN (XARELTO) from 16-Jun-2014 to an unknown date for Pulmonary embolism and DVT.    On 06-Oct-2023, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Hurt for a day or two). At the time of the report, VACCINATION SITE PAIN (Hurt for a day or two) had resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Patient had already received 5 Pfizer shots and 1 Spikevax vaccine. Last dose was Spikevax, but she did not remember very well the date, it was probably 6OCT2023, and the only side effect was that it hurt for a day or two.  Caller mentioned that patient was concerned because after the Spikevax shot was given the vaccination provider gave her a sheet with information about the vaccine and it mentioned that previous to get the vaccine she should inform the HCP if she was in a blood thinner, and she was indeed taking Xarelto.  Treatment Medication use information was not provided by reporter.
I was immediately confused about where I was at, when leaving the vaccination site.  I immediately felt flush with red splotches on my face.  I came home and took a nap just to sleep it off.  I woke up with severe tinnitus, a headache, and brain fog.  Both the tinnitus and headaches have only gotten worse.  The flush feeling, (suspecting higher blood pressure than usual), comes and goes with more frequency as time goes by.  The ?brain fog? has been more like brain damage.  At first, I just couldn?t think.  My ability to think has slowly improved, but it is no where near the same as my abilities prior to the vaccine.  My memory has been impaired, both long term and short term.   My hand/eye coordination has been impaired.      Prior to the vaccine, I didn?t feel my age.  After the vaccine I felt like I aged 25 years in a week.   I need to figure out what is going on inside my head, and what can be done about it.  The degeneration is a serious concern.  Both in the severity of the adverse reactions, and in the permanence of the damage.  This will be devastating if I?m entering early stages of dementia, decades before the course of natural causes of aging.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On an unspecified date the patient was vaccinated with a dose of ZOSTAVAX (dose and route not reported, lot# L035505 with expiration date 16-DEC-2015). Concomitant medications were not reported. On an unknown date the patient experienced injection site swelling and redness that warm to the touch, headache, and "generalized achiness". Outcome of the events was unknown. The causality was not provided. This is one of several reports received from the same reporter. Additional information has been requested.
Significant left shoulder pain that developed shortly after the vaccine was given and was persistent.  Ultimately she underwent rotator cuff repair
This spontaneous report was received from a nurse refers to two patients of unknown age and gender. Medical history was not reported. The nurse informed that on 11-AUG-2014 the patients were vaccinated with MMR II (strength, dosage and route were not reported) lot number: J013315, expiration date: 18-OCT-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the MMR II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
On March 19, 2021, a bit more than two weeks after receiving her second COVID-19 vaccine, my mother was suddenly unable to stand up and walk steadily without support. Up to this point she was living 100% independently in a tri-level home with stairs, managing all of her own finances, preparing all of her meals, etc. From that day on her mobility quickly began to fail; she experienced constant edema; she very quickly progressed from mild cognitive impairment to dementia; she was no longer able compose an email or work something as simple as a TV remote. She moved in with me then to assisted living on April 13, 2021. She was in and out of the hospital constantly due to unwitnessed falls and began developing wounds on her feet. (She did not have diabetes.) By mid-August 2021 she entered hospice and died on August 31, 2021. Her cause of death was listed as advanced dementia. She was fine through March 18, 2021.
Inflammatory reaction to flu vaccine Cellulitis, inguinal nodes, swelling, redness and warm to touch. Keflex.
Had severe reaction to the vaccine not necessarily adverse events but still wanted to report it. I am a physician who likely had contracted COVID in 04/2020 and has been suffering long COVID sx since. No significant reaction to dose 1 of the Pfizer vaccine other than sore arm. 2nd dose within 12 hours had severe rigors, severe chills, then fever to 39.6 the first night (took 1 dose of tylenol and 1 of advil after), temp of 38-39 the next 12 hours, and then the 2nd night had a fever high of 41.4 degrees (took another tylenol). Had sweats the entire night after and defervesced after. Day 3-5 mostly involve myalgia, nausea, anorexia, malaise, chills, HA, and mild SOB. Took about 1 week to "recover" to my long COVID baseline after the 2nd dose of vaccine. Still having a bit worse SOB now compared to prior to 2nd dose but unsure if it has to do with the vaccine at this point. Had tested for positive anti-spike protein ab (likely from the 1st dose) the morning of my 2nd dose of vaccine.
HEADACHE; PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a 57 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced pain at injection site. On 11-APR-2021, the subject experienced headache. On 26-APR-2021, treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain at injection site on 12-APR-2021, and had not recovered from headache. This report was non-serious.
Information has been received from a physician (allergist) concerning a female between 18 to 20 years old who on 11-JAN-2007 was vaccinated with first dose of Gardasil. Concomitant therapy included dicloxacillin from 04-JAN-2007 to 14-JAN-2007. On 28-JAN-2007, the patient developed a hives rash over her arms and legs when administered the vaccine. The patient sought unspecified medical attention.  Additional information has been requested.
Started breaking out in hives morning of 9/16, hives got progressively worse throughout that day and continued for 4 days. Started taking oral Benadryl 50 mg every 6 hours evening of the 16. Started Medrol dose pack morning of 9/18. Oral meds not helping, so went to urgent care clinic and received IM Decadron.  Hives improved slightly, but then worsened again.  Returned to urgent care and received second shot of Decadron on Sunday 9/20. Hives improved again and finally went away.
This case was reported by a consumer (also the subject) and described the occurrence of possible temporal arteritis in a 53-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. On 1 November 2011 the subject received 2nd dose of HAVRIX (details unknown). On 25 November 2011, 24 days after vaccination with HAVRIX, the subject experienced headaches, which "felt like a severe stabbing on the inside". The headaches occurred every day for the next month and in January 2012, the headaches began to go away. However, in January 2012, the subject began to have muscle pain which moved from his legs to his shoulders and forearms. According to the subject, his "knees felt arthritic". Within months after vaccination with HAVRIX, "lately", he has wrist pain and pain in forearm and hand. He has experienced visual problems described as eye muscle pain, blurred vision and double vision. The subject physician thought that the subject had temporal arteritis and he had a biopsy of a 1 inch piece of artery from his left and right temple. The subject reported that the muscle pains are worse at night. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified.
HEART ATTACK; This spontaneous report, a hearsay case, received from a consumer from a recording concerned a 7 decade old male of unknown ethnicity. The patient's height, and weight were not reported. The patient was epileptic. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included acetylsalicylic acid, atorvastatin, carbamazepine, cetirizine, clopidogrel bisulfate, ezetimibe, metoprolol, phenytoin, and piroxicam. On an unspecified date, the patient experienced heart attack and It was not clear if it was before or after patient received the covid-19 vaccine. Consumer stated that patient had a conversation with his neurologist in AUG-2021. The action taken with covid-19 vaccine was not applicable. The outcome of heart attack was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210905680-COVID-19 VACCINE.-Heart attack. This event is considered unassessable. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine).    Concomitant product use was not provided by the reporter.  The nurse stated that it happened because of the monovalent vaccine with the purple border was labeled booster doses.  Treatment information was not provided.
V-vax #2 vaccination on 12/8/09. On 12/9/09 injection site became swollen. On 12/10/09 patient in office to be checked. Swollen @ injection site. Approx. 5 inch oval shaped raised area.
Intense headache; Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Intense headache) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced HEADACHE (Intense headache) and VACCINATION SITE SWELLING (Swelling at the injection site). On 09-Apr-2021, HEADACHE (Intense headache) had resolved. On 10-Apr-2021, VACCINATION SITE SWELLING (Swelling at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported to have use Acetaminophen (Tylenol) as treatment.   This case was linked to MOD-2021-114439 (Patient Link).
Pt recvd vax 1DEC92 & evening 4DEC93 began to exp nausea, weakness, mild flu-like sx which lasted 72 hrs; a separate virus & not in fact a react to vax;
heart palpitations; chills; nauseous; dizzy; previous steroids shot was given on 20Feb2021; previous steroids shot was given on 20Feb2021; This is a spontaneous report from a contactable nurse. A 82-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EP7534, Expiry date: unknown) (age at the time of vaccination was 82 years), administered in Arm Left on 24Feb2021 at 12:57 as dose 2, single for COVID-19 immunization. The patient's medical history included neck problem received 6 or 7 cortisone injections, for a nerve rubbing a bone, heart palpitations. Historical vaccine included shingles vaccine had a slight reaction to the shingles vaccine that took last summer. The patient's concomitant medication was not reported. The patient did not take any other vaccine in four weeks prior COVID -19 vaccine. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EL3249), administered in Arm Left on 20Jan2021 at 12:40 as dose 1, single for COVID-19 immunization. The patient had sore arm/numb arm while taking first dose. The patient was really happy, but had some side effects. On 20Feb2021, the patient received steroids shot given in between vaccine doses. The patient had chills after getting second dose of the vaccine. The patient was fairly dizzy and kind of nauseous the first night. The patient know that chills were part of the Covid-19 vaccine, but wants to know how long would expect to have the chills before it goes away. Where patient first came home he was very excited and also had heart palpitations. The patient had heart palpitations before vaccine also. Got through the night alright. The patient was concerned about it. Once patient get under covers he was ok. Thought the chills would gradually go away would be less each day. The outcome of the events was unknown.  No follow-up attempts were possible. No further information was expected.
I should have gotten my period for my menstrual cycle staying a day or two after the vaccine, but now 7 days later I have not gotten my period and I have a negative pregnancy test. I have never missed my period with the expedition of the pregnancies. I'm never late on my period  but sometimes am early. This is not typical for me and I am meticulous on charting my menstrual cycles.
Sometimes the arm will itch but there is no rash; large reddening area on that arm where I got my injection, about 4" wide by 6" long; Tender when I push on my arm where the injection is,Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Sometimes the arm will itch but there is no rash), VACCINATION SITE ERYTHEMA (large reddening area on that arm where I got my injection, about 4" wide by 6" long) and VACCINATION SITE PAIN (Tender when I push on my arm where the injection is,Sore arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Sometimes the arm will itch but there is no rash), VACCINATION SITE ERYTHEMA (large reddening area on that arm where I got my injection, about 4" wide by 6" long) and VACCINATION SITE PAIN (Tender when I push on my arm where the injection is,Sore arm). At the time of the report, VACCINATION SITE PRURITUS (Sometimes the arm will itch but there is no rash), VACCINATION SITE ERYTHEMA (large reddening area on that arm where I got my injection, about 4" wide by 6" long) and VACCINATION SITE PAIN (Tender when I push on my arm where the injection is,Sore arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medicines reported. No treatment information reported.
Excessive joint pain in fingers, toes, and lower back. Preventing sleep and limiting physical activity.
Fever and flu like 24 hr after 2nd dose. Arm pain. Than few weeks later asthma symptoms with no other signs or fever. Continued for few wks. Now diagnosed with upper R lobe pneumonia
hepatitis B vaccine (21-MAR-2018, 21-MAY-2018),; This spontaneous report has been received from a lawyer, via Immunization Summary from a case in litigation for zoster vaccine live (ZOSTAVAX) (MARRS # 1912USA002078), concerning to 66 years old male patient. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided.  On 21-MAR-2018 and 21-MAY-2018, the patient was vaccinated with hepatitis b vaccine (recombinant)(manufacturer unknown) (dose, strength, route, lot number and expiration date were not reported) for prophylaxis, respectively (inappropriate schedule of product administration).         This is one of two cases concerning the same patient.; Sender's Comments:  US-009507513-1912USA002078:
Patient called today stating initial flare of 1-2 inches at injection site then subsided. Reporting redness has come back with decreased size- also feeling feverish but hasn't taken temp. Also states headache.
This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (aching legs) and PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jan-2022, the patient experienced PAIN IN EXTREMITY (aching legs) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (aching legs) and PYREXIA (Fever) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
high fever the day after injection w/ some malaise & h/a, then resolved; no other s/sx;
Pt recvd 1 dose of Engerix-B & subsequently devel paresthesia; event is reported to have resolved w/o treatment;
Within and hour and a half of receiving developed tinnitus in both ears lasting 6 hours. The night after receiving vaccine also developed orthostatic hypotension and started to pass out but caught myself with an assisted fall.  Fever(102 F with temporal and oral thermometer) body aches/sweats/general malaise lasting close to 24 hours after receiving vaccine. Fever/aches treated with acetaminophen.
3 days ago FLUMIST at 08:45.  C/o itching 0300 & next AM back of legs with hives.  Took Benadryl which helped.  Recurred and lasted 2 days now resolving.  No dyspnea. No prior FLUMIST.  Exam normal but for 3 small wheals left elbow.
Encounter Date: 10/19/2023   1135: Upon administration of vaccines, patient experienced syncope episode. MA administered Hep A, Varicella, IPV whole patient was sitting down. Patient eyes rolled back, lips pale, unable to respond, generalized tonic movements in extremities. Patient was immediately laid down and vitals were taken.   NPs at patient bedside immediately. Patient unable to respond despite sternal rub. Patient turned to his left side.   1138: BP 133/82 HR 53 room air Patient regained consciousness and began crying, asked for his mom. Mom at bedside.   1139: BP 114/68 HR 63 Patient encouraged to take deep breaths, able to answer questions but obtunded affect.   1146: BP 105/58    Patient able to answer questions.   1150: NP assisted patient to sit up 90 degrees and drink juice. Patient denies dizziness, nausea, blurry vision. Per mom, patient gets "nervous" but has never had a syncope episode. Patient drank soup before clinic visit today. Denies previous medical hx, recent illness or trauma.    1156: BP 102/59 HR 73   1200: Patient able to stand and walk without assistance. Patient speaking in full sentences, AOX3, NAD. Informed mom to notify staff at next vaccine appt that patient had a syncope episode to take proper precautions. Mother verbalized understanding.
tingling sensation; cannot talk straight; pain in left arm; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation), SPEECH DISORDER (cannot talk straight), VACCINATION SITE PAIN (pain in left arm) and NAUSEA (nauseous) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling sensation), SPEECH DISORDER (cannot talk straight), VACCINATION SITE PAIN (pain in left arm) and NAUSEA (nauseous). At the time of the report, PARAESTHESIA (tingling sensation), SPEECH DISORDER (cannot talk straight), VACCINATION SITE PAIN (pain in left arm) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were reported.
Fever - T - 102.0 F. Hives in differrent areas on body, legs, face at different times throughout the day after immunization.